West Pharmaceutical targets 2-3% organic sales growth for 2025, highlights GLP-1 market expansion
Q4 2024 Management View CEO Eric Green highlighted that the company achieved 3.3% organic revenue growth in Q4 2024, marking a return to quarterly growth. Notable drivers included strong performance ...